Department of Health Policy

Developed in a region with the world’s highest HIV prevalence, this study design and intervention has the potential to impact testing uptake among a “hidden population” by mobilizing trained healers, who vastly outnumber allopathic care providers in South Africa.

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

Infectious diseases researcher H. Keipp Talbot, MD, MPH, has been appointed chair of the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention.

This year’s Vanderbilt Child Health Poll shows that over 40% of Tennessee families report they are food insecure ― a similar proportion from last year. Most families (71%) say they have continued to change food spending habits due to high prices.

The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.

Vanderbilt's Sarah Jaser, PhD, and Stephen Patrick, MD, MPH, MS, and Jeffrey Upperman, MD, have been elected to the American Pediatric Society.

The current flu season has started later and more gradually than last year although cases are expected to begin increasing in November before falling off in March.